Felix Y Feng

Canonical AREs are tumor suppressive regulatory elements in the prostate

A. Sboner, E. Davicioni, F. Khani, 2024, bioRxiv.

Delayed definitive management of localized prostate cancer: what do we know?

Julian C. Hong, Mack Roach, Y. R. Li, 2024, Prostate cancer and prostatic diseases.

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer

W. Zwart, S. Dehm, J. Alumkal, 2024, Nature genetics.

Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression.

K. Farh, H. Dang, J. Alumkal, 2024, Nature cell biology.